ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1635

Identification Of Novel Genetic Associations Within Major Histocompatibility Complex (MHC) Class I and Class II In Systemic Lupus Erythematosus (SLE) Patients:  An Examination Of Epitopes Of Early Autoimmunity

Gerard Dumancas1, Chee Paul Lin2, Indra Adrianto1, Jennifer A. Kelly1, Stuart B. Glenn1, Jourdan Anderson2, John B. Harley3,4, Timothy J. Vyse5, Robert P. Kimberly6, Marta E. Alarcon-Riquelme7, Carl D. Langefeld8, Betty P. Tsao9, Lindsey A. Criswell10, Chaim O. Jacob11, Patrick M. Gaffney12, Kathy Sivils12, Judith A. James12,13 and Courtney Montgomery2, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Division of Rheumatology and The Center for Autoimmune Genomics & Etiology, University of Cincinnati, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 4US Department of Veterans Affairs Medical Center, Cincinnati, OH, 5Medical & Molecular Genetics, King's College London, London, United Kingdom, 6Clinical Immun & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 7Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Center for Genomics and Oncological Research Pfizer-University of Granada-Junta de Andalucia, Oklahoma City, OK, 8Center for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 9Division of Rheumatology, Department of Medicine, David Geffen School of Medicine University of California Los Angeles, Los Angeles, CA, 10Department of Medicine, University of California, San Francisco, Rosalind Russell Medical Research Center for Arthritis, San Francisco, CA, 11Division of Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA, 12Oklahoma Medical Research Foundation, Oklahoma City, OK, 13College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: autoantibodies, genetics, human leukocyte antigens (HLA), major histocompatibility complex (MHC) and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus-Human Etiology and Pathogenesis: Genetics and Genomics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibody production, multiple organ involvement, strong genetic predisposition and specifically, to be associated with Class II alleles within the Major Histocompatibility Complex (MHC). Immunochemistry studies have shown that specific antibodies often occur years before clinical diagnosis and accrue new specificities through preclinical and clinical phases of SLE. More specifically, specific epitopes appear to be unique to SLE patients early in the course of disease evolution, even compared to other rheumatic diseases. The goal of our study was to better characterize the role of the genes within the MHC by assessing genetic association between antibodies to early epitopes of SmB’, SmD1 and 60kD Ro (termed here GMR, GRx4 and Ro169, respectively) in 703 SLE European-American  (EA) and 557 African American (AA) SLE cases. We also assessed genetic association with autoantibodies directed against the parent lupus autoantigens, Sm and 60kD Ro, in both races.

Methods: Standardized ELISA assays tested serum samples for binding of SmB’: amino acid sequence PPPGMRPP (GMR); SmD1: Glycine Arginine repeat sequence (GRx4); 60kD Ro: amino acids 169-180 (Ro169). Levels of anti-Sm and anti-Ro60 were determined by Bio-Rad Bioplex2200 ANA testing.  All data are semi-quantitative and only measured in SLE patients.  This is in contrast to previous studies, which assessed genetic association of the dichotomous trait, positive versus negative by immunodiffusion asays. 

We evaluated > 50,000 SNPs within the MHC in both EA and AA samples. SNP data were collected from Affymetrix Genome-Wide Human SNP Array 5.0, Illumina iSelect Infinium II, and Immunochip and imputed with IMPUTE2. Quality control included removing of SNPs with call rate <90%, minor allele frequency <0.01 and Hardy-Weinberg proportion tests P < 0.001. 

Results: Autoantibodies against the GRx4) yielded a novel association within the Class I region, with the most significant SNP near TRIM40/TRIM15 in EAs (P < 5 x10-7) and near TRIM39 in AAs (P < 5 x10-5). The Ro169 was also strongly associated in EAs at this location (P < 5 x10-5). Autoantibodies against the GMR showed no association with Class I genes but was significant for Class II (P < 5 x10-4, nearest DQB1) in the same race. Both Sm and 60kd Ro autoantibody responses were also significantly associated within the Class I region (P < 5 x10-5 and P < 5 x10-4, respectively) in the EAs. 60kD Ro was also highly significant (P < 5 x10-8) within the Class II region at DRB1, DQB1 and DQA1 in EAs.  Further conditional analysis showed the driving effect to be within HLA-DQA1. The AA sample was significant for DQB1 and DQA1 (P < 5 x10-6) for the 60kD Ro epitope. 

Conclusion: Our genetic study of the MHC region identified novel association between autoantibody responses against some of the earliest epitopes of lupus, their parent proteins and Class I variants. We further confirmed and more specifically characterized association between Class II variants and 60kd Ro.  These findings and other investigations into the genetic mechanisms underlying early lupus autoimmunity will give significant insight into disease etiology.


Disclosure:

G. Dumancas,
None;

C. P. Lin,
None;

I. Adrianto,
None;

J. A. Kelly,
None;

S. B. Glenn,
None;

J. Anderson,
None;

J. B. Harley,
None;

T. J. Vyse,
None;

R. P. Kimberly,
None;

M. E. Alarcon-Riquelme,
None;

C. D. Langefeld,
None;

B. P. Tsao,
None;

L. A. Criswell,
None;

C. O. Jacob,
None;

P. M. Gaffney,
None;

K. Sivils,
None;

J. A. James,
None;

C. Montgomery,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-novel-genetic-associations-within-major-histocompatibility-complex-mhc-class-i-and-class-ii-in-systemic-lupus-erythematosus-sle-patients-an-examination-of-epitopes-of-earl/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology